<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03101150</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00008644</org_study_id>
    <nct_id>NCT03101150</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia</brief_title>
  <official_title>Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Fahad Medical City</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Fahad Medical City</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine
      daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose
      (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia
      cases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D3 has key role in decidualization and implantation of placenta.Vitamin D deficiency
      is thought to have positive association with pre-eclampsia.Vitamin D deficiency is highly
      prevalent in some parts of the world and it is not universally screened antenatally.
      Pre-eclampsia is a known multifactorial pregnancy disorder with significant maternal and
      perinatal morbidity and mortality. Vitamin D3 has a down-regulating effect on inflammatory
      pathways and reducing endothelial cell damage.

      Investigators want to assess in vitamin D deficient group whether treatment reduces the risk
      of pre-eclampsia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2012</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">October 31, 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of pre-eclampsia events in both arms</measure>
    <time_frame>From 20 weeks of pregnancy till event of pre-eclampsia seen, whichever came first, assessed up to 32 weeks.</time_frame>
    <description>Occurrence of pre-eclampsia or not in all patients irrespective of Vitamin D dose.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin D level</measure>
    <time_frame>At 36th week of pregnancy</time_frame>
    <description>Level of Improvement in Vitamin D status in both arms</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of patients with intrauterine growth retardation</measure>
    <time_frame>At delivery</time_frame>
    <description>Patients having fetus with retardation of growth in both arms.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">179</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>400 IU Vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400IU vitamin D3 contained in antenatal multivitamin once daily by mouth starting from 14 weeks of pregnancy till delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4000 IU Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4000 IU Vitamin D3 drops once daily by mouth starting from 14 weeks of pregnancy till delivery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>400 IU Vitamin D3</intervention_name>
    <description>Antenatal multivitamin</description>
    <arm_group_label>400 IU Vitamin D3</arm_group_label>
    <other_name>Materna</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4000 IU Vitamin D3</intervention_name>
    <description>4000 IU Vitamin D3 (cholecalciferol) daily = 40 drops daily</description>
    <arm_group_label>4000 IU Vitamin D3</arm_group_label>
    <other_name>Vidrop</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed singleton pregnancy of less than 13 completed weeks of gestation at the time
             of consent.

          -  Planned to receive antenatal care in King Fahad Medical City antenatal clinic.

          -  The ability to provide written informed consent at the first visit.

          -  Low risk pregnancy; and Serum vitamin D3 levels less than &lt; 25nmol/L.

        Exclusion Criteria:

          -  Mothers with pregnancy with abnormal foetus.

          -  Previous history of hypertension, pre-eclampsia, recurrent miscarriages.

          -  Chronic kidney disease, chronic liver disease, and malignancy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant population</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Fahad Medical City</investigator_affiliation>
    <investigator_full_name>Aisha Mansoor Ali</investigator_full_name>
    <investigator_title>Assistant Consultant Obstetric and Gynecology</investigator_title>
  </responsible_party>
  <keyword>Maternal vitamin D</keyword>
  <keyword>Deficiency</keyword>
  <keyword>Insufficiency</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Pre-eclampsia</keyword>
  <keyword>IUGR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 6, 2017</submitted>
    <returned>May 12, 2017</returned>
    <submitted>August 17, 2017</submitted>
    <returned>February 23, 2018</returned>
    <submitted>February 24, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

